健达九州(北京)生物科技有限公司于2022年3月2日成立,注册资本为318.5897万元,注册地址北京市昌平区学智路8号院生命谷国际精准医学产业园3号楼3层301,主营业务为重大脑疾病和恶性脑肿瘤的基因治疗。公司是由神经科学领域知名科学家、北京脑科学与类脑研究所联合主任罗敏敏教授创立,在研管线10个,累计申请或受让发明专利(含PCT)8项,已获得国家发明专利1项。陆续获评中关村高新技术企业、创新型中小企业、北京市“专精特新”中小企业、国高新,研发实力与管线前景受到资本市场高度认可,2022年12月8日完成了1亿元天使轮融资,目前企业正处于高速发展期,公司员工共计48人,硕士及以上学历人员占比77%。
What does 健达九州(北京)生物科技有限公司 require? Who is 健达九州(北京)生物科技有限公司 hiring? recruitment: 医疗卫生/美容保健类占比最多占35.9%,其次是计算机/网络/技术类占35.9%. What education can get in at ? 本科占比最多占56.4%,其次是硕士占25.6%. High education required at ? 硕士占25.6%,博士占12.8%. Work experience required at ? 1-3年占比最多占43.6%,其次是不限占43.6%. Where are the job locations at ? 北京占比最多占100%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows